Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Covington
Accenture
Chubb
Colorcon
Mallinckrodt
Cantor Fitzgerald
Teva
Fuji

Generated: February 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Emblaze Ltd. v. Apple Inc. (N.D. Cal. 2011)

« Back to Dashboard

Emblaze Ltd. v. Apple Inc. (N.D. Cal. 2011)

Docket ➤ Try a Free Trial Date Filed 2011-03-11
Court District Court, N.D. California Date Terminated 2014-07-11
Cause 15:1126 Patent Infringement Assigned To Paul Singh Grewal
Jury Demand Both Referred To Joseph C. Spero
Parties AKAMAI TECHNOLOGIES, INC.; APPLE INC.; EMBLAZE LTD.; MICROSOFT CORPORATION
Patents 6,031,003
Attorneys Andrew P. Nemiroff; David H. Judson; Eduardo J Blanco; Edward Murray Weisz; Eric Lance Wesenberg; Erin Paige Gibson; Jacob Daniel Anderson; James Joseph DeCarlo; John Allcock; Julie Pamela Bookbinder; Julie Pamela Bookbinder ,; Kenneth L. Steinthal; Krista Anne Celentano; Lisa A. Ferrari; Marilyn Neiman; Mark Fowler; Mark V. Isola; Martin Brian Pavane; Martin L. Fineman; Michael A. Nicodema; Nathan Dooley; Robert Buergi; Robert Chen Williams; Roger S. Thompson; Sarah Elizabeth Barrows; Scott J Bornstein; Scott J. Bornstein; Stephen M. Ullmer; William Sloan Coats , III
Firms Andrew P. Nemiroff; Cohen, Pontani, Lieberman & Pavane; Cozen OConnor; Davis Wright Tremaine LLP; DLA Piper LLP; DLA Piper LLP (US); DLA Piper US; Greenberg Traurig; Greenberg Traurig LLP; Greenberg Traurig LLP (Sta Monica), MetLife Building; Greenberg Traurig LLP, MetLife Building; Greenberg Traurig, LLP (NYC); King & Spalding; Law Office of David H. Judson; Lisa A. Ferrari; Martin Brian Pavane; Nathan Dooley; Novak Druce Connolly Bove Quigg LLP; Perkins Coie LLP; Rehon & Roberts
Link to Docket External link to docket
Small Molecule Drugs cited in Emblaze Ltd. v. Apple Inc.
The small molecule drug covered by the patent cited in this case is ➤ Try a Free Trial .
Biologic Drugs cited in Emblaze Ltd. v. Apple Inc.
The biologic drug covered by the patent cited in this case is ➤ Try a Free Trial .

Details for Emblaze Ltd. v. Apple Inc. (N.D. Cal. 2011)

Date Filed Document No. Description Snippet Link To Document
2014-05-20 430 Exhibit 1 Jun-09 $ 10,154 $ 7,006 31% $ 3,148 $ 1,015 10% $ 1,320 $ 1,828… 1495The current patent portfolio includes numerous patents. "Patent Portfolio," mp3licensing.com… or for the non-patented components, and when patented product and the non-patented product…;473 Patent is valid and enforceable. c) The asserted claims of the '473 Patent (hereinafter… U.S. Patent No. 6389473 81, "Network Media Streaming." See also, Patent Assignment Abstract External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chubb
Federal Trade Commission
Johnson and Johnson
Citi
Accenture
Express Scripts
Queensland Health
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.